✦ LIBER ✦

Valvular heart disease in patients with Parkinson’s disease treated with pergolide, levodopa or both

✍ Scribed by Feriha Ozer; Raziye Tiras; Sibel Cetin; Oya Ozturk; Tuba Aydemir; Serkan Ozben; Hasan Meral; Sibel Kizkin; Halit Bader; Beste Ozben

Book ID: 116674608
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 109 KB
Volume: 16
Category: Article
ISSN: 0967-5868
DOI: 10.1016/j.jocn.2008.02.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Valvular heart disease in patients with

Valvular heart disease in patients with Parkinson’s disease treated with pergolide. Course following treatment modifications

✍ D. Dupuy; J. P. Lesbre; P. Gérard; M. Andrejak; O. Godefroy 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 168 KB

Valvular heart disease in a patient with

Valvular heart disease in a patient with Parkinson's disease treated with a low daily dose and a low cumulative dose of pergolide

✍ Eun Joo Chung; Won Tae Yoon; Ji-Youn Kim; Won Yong Lee 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views

Mortality of patients with parkinson's d

Mortality of patients with parkinson's disease treated with levodopa

✍ R. J. Marttila; U. K. Rinne; T. Siirtola; V. Sonninen 📂 Article 📅 1977 🏛 Springer 🌐 English ⚖ 372 KB

The effect of levodopa on the mortality of patients with Parkinson's disease was investigated in 349 patients treated with levodopa or levodopa combined with decarboxylase inhibitor during 1969-1975 inclusive. During the study period, 61 patients died. The expected mortality was 32.99 resulting in a

Ocular dyskinesias in patients with Park

Ocular dyskinesias in patients with Parkinson's disease treated with levodopa

✍ Natsue Shimizu; Dr. Bernard Cohen; Stanley P. Bala; Marina Mendoza; Melvin D. Ya 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB 👁 2 views

Cysteine elevation in levodopa-treated p

Cysteine elevation in levodopa-treated patients with Parkinson's disease

✍ Thomas Müller; Wilfried Kuhn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 1 views

## Abstract Homocysteine, cysteine, and cysteinyl‐glycine are all metabolically interrelated. Levodopa/decarboxylase inhibitor (LD/DCI) administration increases total homocysteine (tHcy) plasma levels. Objectives were to investigate associations between LD/DCI intake, concentrations of tHcy, cystei

Hyperhomocysteinemia in levodopa-treated

Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia

✍ Stefano Zoccolella; Claudia dell'Aquila; Giovanni Abruzzese; Angelo Antonini; Ub 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

## Abstract Dementia is a frequent non‐motor feature of Parkinson's disease (PD). Elevated plasma homocysteine (Hcy) levels have been associated with both cognitive impairment and dementia. Increased Hcy levels have been observed in levodopa‐treated patients with PD. The objective of our study was